Lipids that increase insulin sensitivity and methods of using the same
US11174216B2 · kind B2 · utility
0Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 8, 2018 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Apr 6, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/04
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.